S
ALNY icon

Seeyond’s Alnylam Pharmaceuticals ALNY Stock Holding History

Seeyond’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$104K Sell
438
-6,189
-93% -$1.32M 0.01% 556
2022
Q3 		$1.33M Buy
6,627
+3,091
+87% +$590K 0.16% 189
2022
Q2 		$515K Sell
3,536
-71
-2% -$10.1K 0.06% 447
2022
Q1 		$588K Sell
3,607
-3,837
-52% -$585K 0.06% 447
2021
Q4 		$1.26M Hold
7,444
– – 0.12% 295
2021
Q3 		$1.41M Sell
7,444
-2,311
-24% -$434K 0.14% 255
2021
Q2 		$1.65M Buy
9,755
+44
+0.5% +$6.44K 0.15% 218
2021
Q1 		$1.37M Sell
9,711
-10,457
-52% -$1.57M 0.14% 243
2020
Q4 		$2.62M Buy
20,168
+2,935
+17% +$392K 0.27% 84
2020
Q3 		$2.51M Buy
17,233
+1,802
+12% +$256K 0.27% 84
2020
Q2 		$2.29M Buy
15,431
+9,048
+142% +$1.22M 0.26% 93
2020
Q1 		$364K Buy
6,383
+5,034
+373% +$581K 0.05% 423
2019
Q4 		$155K Hold
1,349
– – 0.02% 570
2019
Q3 		$108K Hold
1,349
– – 0.01% 590
2019
Q2 		$98K Sell
1,349
-296
-18% -$22.7K 0.01% 618
2019
Q1 		$154K Hold
1,645
– – 0.01% 570
2018
Q4 		$120K Buy
+1,645
New +$127K 0.02% 573

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Seeyond's ALNY Position: Q4 2022 in Review

Seeyond reduced its Alnylam Pharmaceuticals (ALNY) stake by 93% in Q4 2022, selling an estimated $1.32M and leaving 438 shares worth $104K. The position accounts for 0.01% of the portfolio, ranked #556.

Seeyond first reported a position in ALNY in Q4 2018 and has held it in 17 quarters since. The position peaked at $2.62M in Q4 2020. 487 funds tracked by Wall St. Rank hold ALNY as of Q4 2022.

  • Seeyond held 438 shares of Alnylam Pharmaceuticals worth $104K as of Q4 2022.
  • Seeyond sold 6,189 Alnylam Pharmaceuticals shares in Q4 2022, an estimated $1.32M.
  • Alnylam Pharmaceuticals made up 0.01% of Seeyond's portfolio in Q4 2022, its #556 holding.
  • Seeyond first reported a position in Alnylam Pharmaceuticals in Q4 2018 and has held it in 17 quarters since.
  • Seeyond's Alnylam Pharmaceuticals position peaked at $2.62M in Q4 2020.
  • 487 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.